| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO
1 company
Rothblatt Martine A is a Chairperson &CEO at UTHR. Recent filings cover 0 purchases and 462 sales. Those positions are worth an estimated $179.8M at current prices.
Our model assigns Rothblatt Martine A a middling insider score of 58/100, based on 304 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.6%.
Rothblatt Martine A's largest disclosed position is in UTHR as Chairperson &CEO, worth about $179.8M. The recent filings there lean toward selling, a net 347,599 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $511.97 | $4,863,730.12 | -2.8% | |
| Aug 21, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,730 | $517.56 | $5,035,900.76 | -2.9% | |
| Aug 20, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $521.02 | $4,949,716.74 | -2.8% | |
| Aug 19, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $526.96 | $5,006,103.75 | -2.8% | |
| Aug 18, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $515.60 | $4,898,221.00 | -2.8% | |
| Aug 17, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $506.59 | $4,812,568.34 | -2.8% | |
| Aug 14, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $498.91 | $4,739,664.29 | -2.8% | |
| Aug 13, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 8,887 | $505.16 | $4,489,324.61 | -2.7% | |
| Aug 12, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $515.03 | $4,892,748.14 | -2.8% | |
| Aug 11, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $522.87 | $4,967,291.98 | -2.8% |